Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms
Pharmaceuticals · 09.08.2023 · 16 (8) · 1121
DOI: 10.3390/ph16081121 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 09.08.2023. Verfasst von Estefanie Osorio-Llanes und 13 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Biomedicine Research Group, Faculty of Health Sciences, Universidad Libre de Colombia, Seccional Barranquilla, Barranquilla 081001, Colombia. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Libre de Colombia, Seccional Barranquilla, Faculty of Health Sciences, Universidad Libre de Colombia.
Abstract (Originalsprache)
The search for new drugs with the potential to ensure therapeutic success in the treatment of cardiovascular diseases has become an essential pathway to follow for health organizations and committees around the world. In June 2021, the World Health Organization listed cardiovascular diseases as one of the main causes of death worldwide, representing 32% of them. The most common is coronary artery disease, which causes the death of cardiomyocytes, the cells responsible for cardiac contractility, through ischemia and subsequent reperfusion, which leads to heart failure in the medium and short term. Metformin is one of the most-used drugs for the control of diabetes, which has shown effects beyond the control of hyperglycemia. Some of these effects are mediated by the regulation of cellular energy metabolism, inhibiting apoptosis, reduction of cell death through regulation of autophagy and reduction of mitochondrial dysfunction with further reduction of oxidative stress. This suggests that metformin may attenuate left ventricular dysfunction induced by myocardial ischemia; preclinical and clinical trials have shown promising results, particularly in the setting of acute myocardial infarction. This is a review of the molecular and pharmacological mechanisms of the cardioprotective effects of metformin during myocardial ischemia-reperfusion injury.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Advanced Biomedicine Research Group, Faculty of Health Sciences, Universidad Libre de Colombia, Seccional Barranquilla, Barranquilla 081001, Colombia.
- Allied Research Society S.A.S., Barranquilla 080001, Colombia.
- Global Disease Research Colombia, Barranquilla 080001, Colombia.
- Healthcare Pharmacy and Pharmacology Research Group, Faculty of Chemistry and Pharmacy, Universidad del Atlántico, Barranquilla 081007, Colombia.
- Escuela de Química y Farmacia, Facultad de Medicina, Universidad Andres Bello, Santiago 8370134, Chile.
- Department of Medicine, Faculty of Medicine, Foggy Bottom Campus, George Washington University, Washington, DC 20052, USA.
ORCID-Profile: Estefanie Osorio-Llanes, María Clara Ospino Guerra, Luis Antonio Díaz-Ariza, César Vásquez-Trincado, Aileen Y Chang, Samir Bolívar
Förderung
- Universidad Libre de Colombia, Seccional Barranquilla
- Faculty of Health Sciences, Universidad Libre de Colombia
Zitieren
APA
Osorio-Llanes, E., Villamizar-Villamizar, W., Ospino Guerra, M. C., Díaz-Ariza, L. A., Castiblanco-Arroyave, S. C., Medrano, L., Mengual, D., Belón, R., Castellar-López, J., Sepúlveda, Y., Vásquez-Trincado, C., Chang, A. Y., Bolívar, S., & Mendoza-Torres, E. (2023). Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms. Pharmaceuticals, 16(8), 1121. https://doi.org/10.3390/ph16081121
Vancouver
Osorio-Llanes E, Villamizar-Villamizar W, Ospino Guerra MC, Díaz-Ariza LA, Castiblanco-Arroyave SC, Medrano L, et al. Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms. Pharmaceuticals. 2023;16(8):1121. doi:10.3390/ph16081121
BibTeX
@article{OsorioLlanes2023,
author = {Osorio-Llanes, Estefanie and Villamizar-Villamizar, Wendy and Ospino Guerra, María Clara and Díaz-Ariza, Luis Antonio and Castiblanco-Arroyave, Sara Camila and Medrano, Luz and Mengual, Daniela and Belón, Ricardo and Castellar-López, Jairo and Sepúlveda, Yanireth and Vásquez-Trincado, César and Chang, Aileen Y and Bolívar, Samir and Mendoza-Torres, Evelyn},
title = {Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {8},
pages = {1121},
doi = {10.3390/ph16081121}
}
EUVIMED